Candriam SCA’s Encompass Health EHC Stock Holding History

Candriam SCA’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.71M	Buy	+69,375	New	+$7.11M	0.03%	345
2024 Q4	–	Sell	-82,974	Closed	-$8.02M	–	681
2024 Q3	$8.02M	Buy	82,974 +20,948	+34%	+$1.88M	0.05%	295
2024 Q2	$5.32M	Sell	62,026 -2,958	-5%	-$248K	0.03%	331
2024 Q1	$5.37M	Buy	64,984 +2,304	+4%	+$169K	0.03%	329
2023 Q4	$4.18M	Buy	62,680 +6,680	+12%	+$433K	0.03%	357
2023 Q3	$3.76M	Hold	56,000	–	–	0.03%	341
2023 Q2	$3.79M	Buy	56,000 +47,365	+549%	+$2.97M	0.03%	378
2023 Q1	$430K	Sell	8,635 -7,025	-45%	-$409K	﹤0.01%	803
2022 Q4	$937K	Sell	15,660 -4,247	-21%	-$231K	0.01%	706
2022 Q3	$900K	Buy	+19,907	New	+$996K	0.01%	729

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Candriam SCA's EHC Position: Q1 2026 in Review

Candriam SCA opened a new position in Encompass Health (EHC) in Q1 2026: 69,375 shares worth $6.71M. The stake represents 0.03% of the portfolio and ranks #345 among its holdings. This is a return to the name: Candriam SCA previously reported a position in EHC as recently as Q3 2024.

Candriam SCA first reported a position in EHC in Q3 2022 and has held it in 10 quarters since. The position peaked at $8.02M in Q3 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Candriam SCA held 69,375 shares of Encompass Health worth $6.71M as of Q1 2026.
Encompass Health was a new Candriam SCA position in Q1 2026.
Encompass Health made up 0.03% of Candriam SCA's portfolio in Q1 2026, its #345 holding.
Candriam SCA first reported a position in Encompass Health in Q3 2022 and has held it in 10 quarters since.
Candriam SCA's Encompass Health position peaked at $8.02M in Q3 2024.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.